Please login to the form below

Not currently logged in

Kane & Finkel announces new European director

John Flaherty will handle pan-European clients for the healthcare comms agency

John Flaherty, Kane & Finkel, European Communications 

Kane & Finkel has brought in ApotheCom ScopeMedical's John Flaherty to take on the role of European director.

Based at the agency's London office, Flaherty will be responsible for delivering integrated, multi-channel campaigns for pan-European clients, while also developing new business in the region.

Commenting on his appointment, Flaherty said: “I am looking forward to the exciting developments Kane & Finkel has in progress and to bringing the expertise of a highly creative independent agency to clients in Europe.

“It is refreshing to be part of an agency that takes an entrepreneurial approach to marketing in the healthcare space, and I'm eager for the opportunities such thinking will certainly create.”

Flaherty has experience in strategic planning, advertising and branding, medical education, PR, market access and digital development; having held various leadership positions with GSW Worldwide, Lowe Healthcare, Sudler & Hennessey and Huntsworth Health.

During his career he has worked on a number of award-winning strategies and creative campaigns in prescription, device, diagnostic and OTC categories.

In addition, as director of communications for the UK's Health Education Authority, he also developed public health campaigns for AIDS, smoking cessation, childhood immunisation and heart disease.

John Kane, principal and managing director of Kane & Finkel, said: “John's agency management experience and his knowledge of the European market, allied with his business development success will help further establish Kane & Finkel in this important region.”

8th October 2012

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge